Loading...

Notice

Check the various announcements of oncoMASTER.

[oncoMASTER Director's press release] "Relaxation of university shareholding ratio, development of medical school professor-pharmaceutical cooperation ecosystem" (2022. 09. 22. Medical Times)

2024.02.07 14:39

[oncoMASTER Director's press release] "Relaxation of university shareholding ratio, development of medical school professor-pharmaceutical cooperation ecosystem" (2022. 09. 22. Medical Times)

“Relaxation of university ownership ratio, development of medical school professor-pharmaceutical cooperation ecosystem”

Pharmaceutical companies such as Hanmi and Yuhan Corporation expand investment in digital health and ESG

After 2020, technology holding company subsidiary shareholding will be relaxed from 20% to 10%.

Yuhan Corporation invests 2 billion won in ‘Onco Master’ and acquires 8.0% stake

 

link

https://www.medicaltimes.com/Main/News/NewsView.html?ID=1149587&ref=naverpc

Source: Medical Times (Reporter Seongho Moon_2022. 09. 22)


ONCOCROSS Co., Ltd.

Business registration number: 482-86-00109 | CEO: Yi Rang KIM / Jihoon KANG

Address: Room 905, 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, Korea (Munjeong-dong, Munjeong Hyundai Knowledge Industry Center 1-2)

Email: oncocross@oncocross.com

ⓒ ONCOCROSS CO., LTD. All Rights Reserved.

온코마스터 로고.